Company: AZN
Filing Date: 2025-09-29
Form Type: 6-K
Source: 0001104659-25-094039
Chunk: 48

Company: ASTRAZENECA PLC
Filing Date: 2025-09-29
Form: 6-K
Chunk 48
---
 Uncertificated Securities Regulations 2001.

Holders of AstraZeneca Shares held through the CSN Facility

Holders of AstraZeneca Shares held through the CSN Facility may vote on the day via the online platform, or in advance with Equiniti’s online portfolio service, via the Shareview website, www.shareview.co.uk. Full details and instructions are given on the Shareview website. If you have not yet registered for a Shareview Portfolio, please go to www.shareview.co.uk and enter the requested information. It is important that you register for a Shareview Portfolio to allow enough time to complete the registration and authentication processes. Alternatively, holders can sign and return the CSN Voting Form, in accordance with the instructions included on the CSN Voting Form.

The deadline for the receipt of the CSN Voting Form and/or electronic voting instructions is 2:30 p.m. (GMT) on 29 October 2025, or if this meeting is adjourned, 72 hours (excluding any part of any day that is a non-working day) before the time appointed for holding the adjourned meeting prior to any adjourned meeting.

Holders of AstraZeneca Shares in other nominee services

Holders of AstraZeneca Shares in a nominee account or brokerage account may participate in the General Meeting if they are appointed as a proxy by the registered Shareholder. The holder should contact their nominee account provider to make arrangements for a proxy appointment or letter of representation to be completed. Duly appointed proxies and corporate representatives must contact the Company’s registrar, Equiniti, who will provide details on how to access the General Meeting. Please email: hybrid.help@equiniti.com. The mailbox is monitored 9:00 a.m. to 5:00 p.m. (UK time), Monday to Friday (excluding public holidays in England and Wales).

To ensure a proxy is able to participate, you should provide the required documentation by no later than 2:30 p.m. (GMT) on 30 October 2025.

Please contact your nominee account provider in the first instance to make arrangements.

EquatePlus account

Individuals who hold their interests in AstraZeneca Shares through EquatePlus managed by the nominee of the plan may direct the nominee to vote on their behalf by lodging their instruction online in accordance with the voting instructions received by email.

Appointment of corporate representatives

Any corporation which is a member can appoint one or more corporate representatives who may exercise on its